
Commentary|Podcasts|December 12, 2024
Managed Care Cast Presents: Navigating Burdens and Treatment Challenges of IPF
A trio of experts discuss the importance of early diagnosis, treatment barriers, and therapies in the pipeline for idiopathic pulmonary fibrosis (IPF).
Advertisement
Today we are bringing you insights from 3 separate interviews with experts about the treatment, management, and burdens of idiopathic pulmonary fibrosis (IPF).
In this podcast, you’ll hear insight from the following individuals:
- Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine, University of Southern California
- Martin Kolb, MD, PhD, professor of medicine, McMaster University
- Steven Nathan, MD, FCCP, medical director of the Advanced Lung Disease Program and Lung Transplant Program, Inova Fairfax Hospital, and professor of medicine, University of Virginia
These experts discuss what IPF is, how it impacts patients’ quality of life, barriers to care, and treatments in the pipeline.
Listen above or through one of these podcast services:
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success
2
Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk
3
Predicting GLP-1 Discontinuation From Pharmacy Claims
4
Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis
5




